Neonc Technologies CEO Amir Heshmatpour acquires $49,860 in stock

On August 18, 2026, Amir Heshmatpour, CEO of Neonc Technologies, bolstered his stake in the company by purchasing 9,000 shares of common stock at $5.54 per share. This purchase valued at $49,860 marked a 12.87% rise in the stock price, currently at $5.71. Post-transaction, Mr. Heshmatpour's direct ownership rose to 3,096,000 shares, encompassing 275,000 shares belonging to immediate family members.

Indirectly, he holds 256,120 shares through HCWG LLC, 550,000 shares via KIG LLC, and 3,714,020 shares through AFH Holdings & Advisory, LLC. The CEO's total beneficial ownership now stands at 3,096,000 shares, inclusive of 275,000 shares belonging to selected family members. Neonc Technologies also reported positive Phase 2a study results for NEO100, achieving a primary endpoint with a 48.9% six-month progression-free survival rate, surpassing the 20% benchmark.

The FDA approved manufacturing requirements for NEO212, leading to the cancellation of a scheduled meeting, and the company secured approval from Abu Dhabi's Department of Health for NEO100 and NEO212, enabling further trials in brain cancer treatment.